VPC 01091

Code: 857345P-1MG D2-231

Biochem/physiol Actions

VPC 01091 is a selective sphingosine 1-phosphate receptor-1 (S1PR1) agonist and sphingosine 1-phosphate receptor-3 (S1PR3) antagonist. It confers prot...


read more

Your Price
€343.20 1MG
Discontinued
€422.14 inc. VAT

Biochem/physiol Actions

VPC 01091 is a selective sphingosine 1-phosphate receptor-1 (S1PR1) agonist and sphingosine 1-phosphate receptor-3 (S1PR3) antagonist. It confers protection against lung injury and dysfunction after ischemia-reperfusion (IR) in mice.

General description

This product is covered by Patent Number US 7,754,703. Avanti manufactures this under license from University of Virginia.

VPC 01091 is a sphingosine analog.

Packaging

5 mL Amber Glass Screw Cap Vial (857345P-1mg)

assay>99% (TLC)
formpowder
manufacturer/tradenameAvanti Polar Lipids 857345P
packagingpkg of 1 × 1 mg (857345P-1mg)
shipped indry ice
SMILES stringN[C@](C1)(CO)CC[C@@H]1C2=CC=C(CCCCCCCC)C=C2
storage temp.−20°C
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN


GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.